The role of the thymus in allogeneic hematopoietic stem cell transplantation

Swiss Medical Weekly
Werner Krenger, Georg A Holländer

Abstract

Allogeneic haematopoietic stem cell transplantation (HSCT) is used to treat an increasing number of congenital and acquired disorders of the haematopoietic system. Even though cytoreductive conditioning regimens vary in intensity, all clinically used protocols invariably cause side effects that compromise transiently or long-term the response of the natural and the adaptive immune systems. However, in the context of the reconstruction of immunity, the generation of naïve T cells constitutes a slow process, and requires a functionally competent thymus. Unfortunately, regular thymic function is frequently suppressed by transplant-related toxicities. Most notably, graft-versus-host disease (GVHD) causes a state of posttransplantation immune deficiency. Here we discuss preclinical allogeneic HSCT models and clinical observations that have contributed to a detailed understanding of the cellular and molecular mechanisms responsible for the thymic dysfunction caused by acute GVHD. An in-depth knowledge of the mechanisms that control regular thymopoiesis and, conversely, affect thymus function is expected to provide the factual basis for the design of innovative therapies to recover T-cell numbers and function following allogeneic HSCT.

Citations

Jul 10, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Borislav SavkovicJohn M Murray
Apr 6, 2017·Frontiers in Immunology·Aisling M Flinn, Andrew R Gennery
Apr 30, 2017·Frontiers in Immunology·Irene Calvo-AsensioRhodri Ceredig

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Annual Review of Immunology
Lisbeth A WelniakWilliam J Murphy
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
John KorethLisbeth A Welniak
© 2021 Meta ULC. All rights reserved